Synthesis and Β-Adrenergic Blocking Activity of Oxime Ether Hybrids Derived from a Natural Isochroman-4-one
Bai Ren-Ren,Xu Sheng-Tao,Liu Jie,Hong Wen,Tang Yi-Qun,Wu Xiao-Ming,Xie Wei-Jia,Yao He-Quan,Xu Jin-Yi
DOI: https://doi.org/10.1016/s1875-5364(13)60098-9
IF: 3.887
2014-01-01
Chinese Journal of Natural Medicines
Abstract:AM: In a search for new cardiovascular drug candidates, a series of novel oxime ethers derived from a natural isochroman-4-one were synthesized. METHOD: Compounds 3 and 6, derived from the natural antihypertensive compound 7, 8-dihydroxy-3-methyl-isochroman-4-one (XJP), were designed and synthesized. Subsequently, a series of novel isochroman-4-one codme ether hybrids were prepared by hybridizing various N-substituted isopropanolamine functionalities to isochroman-4-one codme. Furthermore, beta(1)-adrenergic blocking activities of the synthesized compounds were assayed using the isolated rat left atria. RESULTS: Twenty target compounds were obtained, and the preliminary structure-activity relationships were deduced. The most promising compound Ic exhibited beta(1)-adrenoceptor blocking activity (inhibition: 52.2%) at 10(-7) mol.L-1, which was superior to that of propranolol (inhibition: 49.7%). CONCLUSION: The results suggested that natural product XJP/isopropanolamine moiety hybrids may provide a promising approach for the discovery of novel cardiovascular drug candidates.